Asset Strategy Leader, R&D Aesthetics
Core
Matrix leader accountable for an asset from discovery to end-of-life, guiding the creation and execution of comprehensive asset and brand strategies across development, registration, manufacture, and commercialization.
Role type
Senior IC asset strategy leader (pharmaceuticals/biotech)
Builds
Global Asset Strategy, Product Development Plan (PDP), Integrated Evidence Plan, Regulatory Strategy, Brand plans, Operations LRP plans
Domain
Pharmaceuticals/Biotech, R&D Aesthetics, Drug Development Lifecycle
Required skills
Strategic thinking, cross-functional leadership, enterprise-level planning, Go/No-Go decision making, stakeholder influence, competitive analysis, regulatory strategy, commercialization lifecycle management
Preferred skills
Device product development experience, aesthetics programs, global scope experience, mentoring high-performing teams
Technologies
None stated
Responsibilities
Chair Asset Strategy Team (AST) and serve as primary contact for Pipeline Governance; Create and gain endorsement of integrated Global Asset Strategy and Brand Strategy; Analyze emerging data to drive recommendations and mitigate risks; Collaborate with cross-functional teams to ensure program alignment with Target Product Profile (TPP) and budget; Validate program viability from scientific and commercial perspectives; Represent AST at external interactions with regulatory bodies and advisory boards; Coach and mentor team members within the High Performing Teams (HPT) model.
Seniority
Senior, hands-on IC with matrix leadership responsibilities